Andreas Kastenbauer
Partner
Works at MIG Capital
Investor profile | Builders Republic
About
Partner at MIG Capital in Munich, Andreas Kastenbauer invests from Seed to Series B on check sizes of €1 to €10 million. His portfolio reflects a strong expertise in biotech and life sciences, including TIBEAY BioSciences and ASTRA Therapeutics, as well as health technologies like Mimi Hearing Technologies. He sits on the board of all these active investments. Prior to VC, he led IDT Biologika as CEO from 2015 to 2019, accumulating extensive operational experience in the biotech sector.
Profile
- Role
- Partner
- Fund
- MIG Capital
- Nationality
- German